Orthobiologics Market Poised to Grow at Significant Rate During the Forecast Period 2021-2025

Orthobiologics Market Poised to Grow at
Significant Rate During the Forecast Period
2021-2025
“The global orthobiologics market is poised for growth owing to the increased levels of geriatric population,
technological advancements, changing lifestyles and problems related to the musculoskeletal system.”
The global Orthobiologics Market size was valued at USD 5.0 Billion in 2015 and is anticipated to reach USD 10.2
billion by 2025, with a CAGR of 7.5%. Orthobiologics are elements which the orthopedic surgeons use to heal the
wounds more quickly. They are utilized for the healing of injured muscles, ligaments, tendons, and broken bones.
They are made up of substances found in the human body itself. These elements found popularity owing to factor
such as faster healing, quick recovery, and a decrease in the number of hospital visits. The orthobiologics market
provides a huge number of opportunities for growth to its shareholders.
The global orthobiologics market is poised for growth owing to the increased levels of geriatric population,
technological advancements, changing lifestyles and problems related to the musculoskeletal system. The increasing
trends of musculoskeletal procedures are seen to be the biggest driver for the market. Establishing strategic
partnerships for the purpose of marketing is also expected to boost the demand for the global orthobiologics market.
Several merchants are forming strategic partnerships to diversify their businesses, grow their overall market share
and spread out their product offerings. These type of strategic alliances help the organizations to align their
technologies with one another’s inventive medical device range.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/orthobiologics-market
A growth in the global orthobiologics market is projected on account of the requirement for safer, more effective
and modern orthopedic biologic treatment. The rise in the number of obesity and arthritis cases also fuels the
demand for orthobiologics treatment. The bone graft procedure accounted to be the largest segment in the global
orthobiologics market.

The shifting preference to biological implants from mechanical implants is accelerating the growth of this market.
Another important trend that is estimated to enhance the growth of the market over next eight years is the
increase in funds to improve orthobiologics. Factors such as growing advances in technology, the prevalence of a
huge number of chronic and unidentified diseases, initiatives by the government and rise in life expectation may
favorably impact the market growth. Along with this, the rising incidences of injuries by sports & road accidents and
growing awareness among athletes are also driving the demand for the market.
However, lack of clear reimbursement procedures and rigorous rules may create major hindrances for the
orthobiologics demand in the market. The improvements in developing alternatives for pharmaceuticals, for
making medical treatments more preventive than curative along with the country’s policy for decreasing the deficit
in the budget is expected to negatively impact the global orthobiologics market. Furthermore, high costs for the
procedure, lack of reliable clinical trial data and strict regulations for the approval of orthobiologics products may
pose challenges to the market growth over the forecast period.
The global orthobiologics market has been segmented based on its applications and product types. On the basis of
application, the market been classified into spinal surgery, joint replacement & reconstruction, and trauma surgery.
On the basis of product types, the market has been segmented into bone graft substitutes, bone growth
stimulators, and viscosupplements. The bone graft substitutes have further been segmented into demoralized bone
matrix (DBM), bone morph genic proteins (BMP), bone allografts, and bone autographs. Additionally,
viscosupplements has also been further segmented into single injection viscosupplements, 3-injection
viscosupplements, and 5-injection viscosupplements.
Over the past few years, the viscosupplements segments held the largest market share for orthobiologics on
account of huge demand for knee treatment procedures. It is a very effective pain killer. Viscosupplements are
intra-articular injections made of hyaluronic acid which helps in the treatment of osteoarthritis.
North America held the majority of the global orthobiologics market in the recent past. The high demand in the
market was sustained by increased prevalence of arthritis and obesity in the region, rising demand for the
treatment of various diseases such as osteoarthritis and spinal injuries. However, over the next eight years, Asia-
Pacific is projected to witness the highest rate of growth for orthobiologics market. This growth will be majorly
driven by the Indian and Chinese market on account of a huge number of untapped patient population, economical
cost, and medical tourism.
The major industry players operating in the global orthobiologics market include Stryker Corporation, Synthes, Inc.,
Biomet, Inc., DJO Global, Zimmer Holding, Inc., Medtronic, Inc., and Smith & Nephew, Bacterin International, Inc.,
DePuySynthes, Inc., Globus Medical, Inc., and Integra LifeSciences Corporation.
Request Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/orthobiologics-market/request-sample
Market Segment:
Orthobiologics Product Outlook (Revenue, USD Billion, 2014 - 2025)

• Demineralized Bone Matrix(DBM)
• Allograft
• Bone Morphogenetic Protein (BMP)
• Viscosupplementation
• Synthetic Bone Substitutes
• Stem Cell Therapy
Orthobiologics Application Outlook (Revenue, USD Billion, 2014 - 2025)
• Spinal Fusion
• Trauma Repair
• Reconstructive Surgery
Orthobiologics End-use Outlook (Revenue, USD Billion, 2014 - 2025)
• Hospitals
• Orthopedic Clinics
Orthobiologics Regional Outlook (Revenue, USD Billion, 2014 - 2025)
• North America
• U.S
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China

• India
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• South Africa
See More Reports of This Category by Million Insights @
https://www.millioninsights.com/industry/biotechnology

Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.
Our representatives strive to understand diverse client requirements and cater to the same with
the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9
Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand
Galleria, Model Colony, Shivaji Nagar,
Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com
Visit Our Blog: www.millioninsights.blogspot.com